WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke MPrint wurde als Bildmarke am 19.04.2010 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Bildmarke |
| Aktenzeichen | 1049835 |
| Länder | 
|
| Basismarke |
Nr. 09 3 685 386,
21. Oktober 2009
|
| Anmeldedatum | 19. April 2010 |
| Ablaufdatum | 19. April 2020 |
Markeninhaber
885 Avenue Eugène Avinée,
Parc Eurasanté
FR
Parc Eurasanté
FR
Markenvertreter
41 avenue de Friedland
F-75008 Paris
FR
Waren und Dienstleistungen
01
Chemicals intended for industry, research and scientific
use, namely marbles, marked chemicals or chemical probes for
detecting, separating and analysing macromolecular
complexes, organic or inorganic compounds, biological
ingredients, medicines and other substances that are
biologically active in biological fluids such as blood,
serum, plasma, urine, saliva, cell culture surnatant and
cerebrospinal liquid, for medical, biological and veterinary
purposes
05
Biological and chemical preparations and products, for
medical or veterinary purposes, for detecting, separating
and analysing materials within biological fluids such as
blood, serum, plasma, urine, saliva, cell culture surnatant
and cerebrospinal liquid, for medical, biological and
veterinary purposes; medical preparations made from clinical
materials and specimens; medical products derived from
biological fluids, including antibodies and pharmaceutical
or veterinary preparations for checking and testing
purposes; biological products for medical diagnoses,
including antibodies, recombinant proteins, nucleic acids
and peptides for analysing biological fluids such as blood,
serum, plasma, urine, saliva, cell culture surnatant and
cerebrospinal liquid, for veterinary diagnosis and research
purposes
42
Biomedical research and development services for biological,
medical and veterinary products, particularly for treatment,
prevention, medical diagnosis, and monitoring the clinical
status and effectiveness of therapy for patients; research
and development activities under contract in the fields of
biotechnology, genomics, proteomics, gene expression and
protein profiling, the discovery and development of
medicines and the analysis of nucleic acid in the
biomedical, forensics, environmental and food industries;
analysis services provided by laboratories and care centres
relating to testing and dosage of materials consisting of
organic or inorganic compounds and biological ingredients
within biological fluids such as blood, serum, plasma,
urine, saliva, cell culture surnatant and cerebrospinal
liquid; research and development activities under contract
in the fields of medical technology, pharmaceuticals,
biochemistry and genetics, scientific research services for
medical purposes, namely maintaining, testing, extracting
and providing third parties with biological fluids such as
blood, serum, plasma, urine, saliva, cell culture surnatant
and cerebrospinal liquid and ingredients thereof, including
chemical and biological products
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 24. April 2021 | 2021/16 Gaz | Löschung | |
| 03. Dezember 2018 | 2018/52 Gaz | US | RAW: Total Invalidation |
| 20. März 2012 | 2013/14 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 05. Oktober 2011 | 2011/41 Gaz | CH | Ablehnung |
| 15. August 2011 | 2011/35 Gaz | CN | Ablehnung |
| 09. August 2011 | 2011/32 Gaz | EM | Ablehnung |
| 30. Juni 2011 | 2013/13 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 13. Januar 2011 | 2011/2 Gaz | JP | Ablehnung |
| 23. Dezember 2010 | 2011/6 Gaz | RAW: Limitation | |
| 18. Oktober 2010 | 2010/42 Gaz | US | Ablehnung |
| 19. April 2010 | 2010/38 Gaz | FR | Eintragung |
ID: 141049835